Burzynski Clinic

Burzynski Clinic

Growing from a small clinic in 1977 to a major, international cancer center with more than one hundred employees, the Burzynski Clinic is a unique organization providing a wide variety of advanced alternative cancer treatments, including Antineoplaston Treatment and Personalized Treatment.

For over thirty years, Dr. Stanislaw Burzynski’s cancer research has been inspired by the philosophy of the physician, Hippocrates, to “First, do not harm”. True to this philosophy, the treatment regimens developed by him are based on the natural biochemical defense system of the Burzynski Clinic’s body, capable of combating cancer without harming the healthy cells.

Every day, in everything the Burzynski Clinic does, it is proudly committed to these values. Patients’ health and well being are most important to it.

The Burzynski Clinic’s modern and spacious medical facility is designed to provide to the Burzynski Clinic’s patients the highest level of comfort and convenience.

Burzynski Clinic offers a variety of Personalized Treatment options – advanced gene-targeted medications custom-selected for a patient, based on the identification of the oncogenes involved in their particular cancer.

The Burzynski Clinic collaborates on a daily basis with other local health care providers to ensure the most complete and optimal cancer treatments.

The Burzynski Clinic’s services include oncology consultations, genetic markers testing, oncogene testing, health information services, in-house pharmacy for formulary management, nutrition counseling, medication training and patient treatment monitoring.

Burzynski Clinic is conveniently located in the Medical District of West Houston and is easily accessible from the airports and major highways.

The Burzynski Clinic’s medical staff consists of senior physicians, research associates, registered nurses, monitoring nurses and other health care professionals.

The Burzynski Clinic takes pride not only in providing the most advanced personalized cancer treatments, but also in ensuring excellent personalized patient care during the entire treatment.


About burzynskiclinic

“We're switching off the bad genes, which are oncogenes, and we are turning on tumor suppressors; we are simply operating these two different types of molecular switches. And when we are successful, the cancer cells will stop growing and they will die” “This is historically the first Phase ill clinical trial on brainstem Glioma because no chemotherapy advanced to successful Phase II trial and none of the chemotherapy proved efficacious in Phase II trials. Therefore there were no Phase ill trials.”
This entry was posted in Burzynski Clinic and tagged . Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s